Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model

BACKGROUND: Formation of schistosomal granulomata surrounding the ova can result in schistosomiasis-associated liver fibrosis (SSLF). The current standard of treatment is praziquantel (PZQ), which cannot effectively reverse SSLF. The role of the cannabinoid (CB) receptor family in liver fibrosis has...

Descripción completa

Detalles Bibliográficos
Autores principales: Issa, Yasmine Amr, El Achy, Samar Nabil, Mady, Rasha Fadly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684006/
https://www.ncbi.nlm.nih.gov/pubmed/31389521
http://dx.doi.org/10.1590/0074-02760190062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684006/
https://www.ncbi.nlm.nih.gov/pubmed/31389521
http://dx.doi.org/10.1590/0074-02760190062

Ejemplares similares